全文获取类型
收费全文 | 1181篇 |
免费 | 82篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 24篇 |
妇产科学 | 8篇 |
基础医学 | 187篇 |
口腔科学 | 29篇 |
临床医学 | 75篇 |
内科学 | 329篇 |
皮肤病学 | 18篇 |
神经病学 | 107篇 |
特种医学 | 35篇 |
外科学 | 219篇 |
综合类 | 17篇 |
一般理论 | 1篇 |
预防医学 | 90篇 |
眼科学 | 11篇 |
药学 | 72篇 |
中国医学 | 2篇 |
肿瘤学 | 43篇 |
出版年
2024年 | 2篇 |
2023年 | 11篇 |
2022年 | 3篇 |
2021年 | 51篇 |
2020年 | 20篇 |
2019年 | 46篇 |
2018年 | 49篇 |
2017年 | 35篇 |
2016年 | 32篇 |
2015年 | 31篇 |
2014年 | 52篇 |
2013年 | 75篇 |
2012年 | 98篇 |
2011年 | 105篇 |
2010年 | 47篇 |
2009年 | 45篇 |
2008年 | 72篇 |
2007年 | 73篇 |
2006年 | 61篇 |
2005年 | 48篇 |
2004年 | 49篇 |
2003年 | 57篇 |
2002年 | 47篇 |
2001年 | 28篇 |
2000年 | 14篇 |
1999年 | 17篇 |
1998年 | 11篇 |
1997年 | 10篇 |
1996年 | 5篇 |
1995年 | 7篇 |
1994年 | 4篇 |
1992年 | 6篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 6篇 |
1988年 | 7篇 |
1987年 | 3篇 |
1986年 | 8篇 |
1985年 | 7篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1981年 | 1篇 |
1980年 | 3篇 |
1979年 | 1篇 |
1978年 | 4篇 |
1977年 | 1篇 |
1972年 | 1篇 |
1968年 | 1篇 |
1962年 | 1篇 |
1960年 | 1篇 |
排序方式: 共有1271条查询结果,搜索用时 31 毫秒
11.
12.
Gary G. Koch Ingrid A. Amara Julia MacMillan 《Journal of biopharmaceutical statistics》2013,23(3):347-410
This paper discusses alternative statistical models for the analysis of six crossover studies to determine whether better relief of tension headache occurs from treatment with an analgesic plus caffeine (C) than with the analgesic alone (A) or with placebo (P). Each patient in these crossover studies randomly received a pair of distinct medications in such a way as to treat the first two of four headaches with the initial medication in the pair and to treat the third and fourth headaches with the last medication in the pair. In order to have greater power for the C versus A comparison, three times as many patients were randomly assigned to the A:C and C:A sequence groups as to the A:P, C:P, P:A, and P:C sequence groups. An issue of statistical interest for these crossover studies is the extent to which the possibility of unequal carryover effects of the three medications influences the roles of alternative models for data analysis and the interpretation of results. When carryover effects for all three medications are equal, univariate analysis of variance for the difference scores between the average response for the first two headaches and the average response for the third and fourth headaches for each patient provides nearly the same power for pairwise treatment comparisons as more comprehensive multivariate methods for all four headaches. However, for comparisons concerning carryover effects and for treatment comparisons with adjustment for carryover effects, multivariate methods encompassing all four headaches jointly can provide greater power than univariate analysis for difference scores, particularly when there is low intraclass correlation for responses within the same patient. Another noteworthy role for multivariate methods in situations with potentially unequal carryover effects is their capacity to clarify whether multiple types of carryover effects occur across the second, third, and fourth headaches in the respective sequence groups. Multivariate models with alternative specifications of carryover effects are fit to the data from the six crossover studies to compare C, A, and P by weighted least squares. The role of potential variation among centers is addressed in these analyses by the use of stratified proportional means over centers, means of center means, and means ignoring centers. The primary focus of attention in the respective analyses is the evaluation of treatment comparisons with and without adjustment for potential differences among carryover effects of the treatments. Comparisons among carryover effects are assessed as well, but they mainly serve a background purpose since the principal issue is the extent to which findings for treatment comparisons are similar across alternative ways of accounting for potential carryover effects. For all models, the average predicted response across all headaches treated with C was significantly better than that for A or P. For models that adjusted treatment effects for carryover effects in a statistically efficient way, the adjusted direct treatment effect of C was significantly better than that of A or P. Thus, the superiority of C over A found robust support from models both with and without adjustment for potential differences among carryover effects of the treatments. 相似文献
14.
15.
Androgen deprivation therapy remains the backbone of prostate cancer treatment given its pivotal role in the pathogenesis of prostate cancer. The growing knowledge of androgen receptor-independent (i.e. AR-null) prostate cancer cells, however, might advance the treatment paradigm of prostate cancer. Here, we examined the results of two recent studies, published in Cancer Cell by Bluemn and Shukla et al., and their impact in the future management of castration-resistant prostate cancer. 相似文献
16.
17.
Robert D. Nebes Beth E. Snitz Ann D. Cohen Howard J. Aizenstein Judith A. Saxton Edythe M. Halligan Chester A. Mathis Julie C. Price M.Ilyas Kamboh Lisa A. Weissfeld William E. Klunk 《Neuropsychologia》2013
Substantial individual differences exist in the magnitude of the cognitive decline associated with normal aging. Potential contributors to this intersubject variability include white matter hyperintensities (WMH) and preclinical Alzheimer′s disease, evident as increased brain amyloid. This study examined whether older individuals with minimal evidence of WMH and/or brain amyloid-beta (seen on positron emission tomography with the Pittsburgh compound B radiotracer—PiB) still showed significant cognitive decrements compared to the young. Older individuals, conservatively screened for normal range performance on an extensive neuropsychological battery, underwent structural magnetic resonance imaging (MRI) and PiB scans and performed tests of information processing speed, working memory and inhibitory function. The elderly were divided into PiB(+) and PiB(−) groups based on radiotracer retention. There were no significant differences in cognitive performance between PiB(+) and PiB(−) elderly. However, both PiB groups performed significantly worse than did the young on cognitive testing. WMH burden in the same individuals was quantified by consensus ratings using a 10 point scale with a median split defining two groups, WMH(+) and WMH(−). There were no differences in cognitive performance between WMH(+) and WMH(−) individuals, but both WMH groups performed significantly worse than did the young. Older participants who were both PiB(−) and WMH(−) also performed significantly worse than did the young in all three cognitive domains. The present results suggest that normal-elderly individuals whose brain scans show minimal evidence of amyloid deposition or WMH, still demonstrate a major decrement in comparison to younger persons on measures of processing resources and inhibitory efficiency. 相似文献
18.
19.
20.
Reduced risk of relapse after long‐term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B 下载免费PDF全文